Who
Tomas Navratil
Chief Development Officer
Company insider
Files Form 4 as: Chief Development Officer, Glaukos.
In numbers
- Trades disclosed
- 137
- Buys
- 0
- Sells
- 11
- Bought
- $0
- Sold
- $8.5M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 1 Apr 2022
- Last trade
- 5 Oct 2026
- Last filed
- 7 Oct 2026
Companies traded
Activity over time
1 Feb 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 5 Oct 2026filed 7 Oct 2026 | GKOS GlaukosMedical Devices | SEC FORM 4 Sold | $146K888 at $163.93 | filing |
| 5 Oct 2026filed 7 Oct 2026 | GKOS GlaukosMedical Devices | SEC FORM 4 Sold | $54K327 at $164.78 | filing |
| 5 Oct 2026filed 7 Oct 2026 | GKOS GlaukosMedical Devices | SEC FORM 4 Sold | $52K312 at $165.60 | filing |
| 25 Sep 2026filed 28 Sep 2026 | GKOS GlaukosMedical Devices | SEC FORM 4 Sold | $25K167 at $151.70 | filing |
| 25 Sep 2026filed 28 Sep 2026 | GKOS GlaukosMedical Devices | SEC FORM 4 Sold | $21K136 at $152.71 | filing |
| 25 Sep 2026filed 28 Sep 2026 | GKOS GlaukosMedical Devices | SEC FORM 4 Sold | $35K229 at $154.24 | filing |
| 25 Sep 2026filed 28 Sep 2026 | GKOS GlaukosMedical Devices | SEC FORM 4 Sold | $168K1,083 at $154.88 | filing |
| 25 Sep 2026filed 28 Sep 2026 | GKOS GlaukosMedical Devices | SEC FORM 4 Sold | $25K167 at $151.70 | filing |
| 25 Sep 2026filed 28 Sep 2026 | GKOS GlaukosMedical Devices | SEC FORM 4 Sold | $21K136 at $152.71 | filing |
| 25 Sep 2026filed 28 Sep 2026 | GKOS GlaukosMedical Devices | SEC FORM 4 Sold | $35K229 at $154.24 | filing |
| 25 Sep 2026filed 28 Sep 2026 | GKOS GlaukosMedical Devices | SEC FORM 4 Sold | $168K1,083 at $154.88 | filing |
| 16 Sep 2026filed 18 Sep 2026 | GKOS GlaukosMedical Devices | SEC FORM 4 Sold | $17K103 at $163.20 | filing |
| 16 Sep 2026filed 18 Sep 2026 | GKOS GlaukosMedical Devices | SEC FORM 4 Sold | $57K345 at $164.60 | filing |
| 16 Sep 2026filed 18 Sep 2026 | GKOS GlaukosMedical Devices | SEC FORM 4 Sold | $32K191 at $166.20 | filing |
| 16 Sep 2026filed 18 Sep 2026 | GKOS GlaukosMedical Devices | SEC FORM 4 Sold | $77K460 at $167.32 | filing |
| 16 Sep 2026filed 18 Sep 2026 | GKOS GlaukosMedical Devices | SEC FORM 4 Sold | $20K120 at $168.38 | filing |
| 16 Sep 2026filed 18 Sep 2026 | GKOS GlaukosMedical Devices | SEC FORM 4 Sold | $40K234 at $170.95 | filing |
| 16 Sep 2026filed 18 Sep 2026 | GKOS GlaukosMedical Devices | SEC FORM 4 Sold | $6884 at $172.00 | filing |
| 16 Sep 2026filed 18 Sep 2026 | GKOS GlaukosMedical Devices | SEC FORM 4 Sold | $17K103 at $163.20 | filing |
| 16 Sep 2026filed 18 Sep 2026 | GKOS GlaukosMedical Devices | SEC FORM 4 Sold | $57K345 at $164.60 | filing |
News
Glaukos Expands Retinal Pipeline With RevOpsis Deal - Orange County Business JournalGKOS · ocbj.com · 19 Oct 2026
0 headlines in the last 90 days name Tomas Navratil; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.